| scholarly article | Q13442814 |
| P2093 | author name string | Ming-Wei Lin | |
| Sheng-Nan Wu | |||
| Ya-Jean Wang | |||
| An-An Lin | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | skeletal muscle cell | Q66505052 |
| P304 | page(s) | 11-20 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells | |
| P478 | volume | 82 |
| Q42620905 | A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding |
| Q34104378 | A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? |
| Q50547354 | Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons. |
| Q35911716 | Complex impairment of IA muscle proprioceptors following traumatic or neurotoxic injury |
| Q43089818 | Computational insights into the neuroprotective action of riluzole on 3-acetylpyridine-induced ataxia in rats |
| Q49908057 | Effects of Benzothiazolamines on Voltage-Gated Sodium Channels. |
| Q34981338 | Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity. |
| Q92708313 | KCNMA1-linked channelopathy |
| Q33379783 | Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure |
| Q52847963 | Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na(+) and Ca(2+) Overload in Motor Neuron-like NSC-34 Cells. |
| Q37235692 | Neurotransmitter signaling pathways required for normal development in Xenopus laevis embryos: a pharmacological survey screen |
| Q38868221 | Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis |
| Q34755164 | Partial block by riluzole of muscle sodium channels in myotubes from amyotrophic lateral sclerosis patients. |
| Q90095494 | Persistent sodium current blockers can suppress seizures caused by loss of low-threshold D-type potassium currents: Predictions from an in silico study of Kv1 channel disorders |
| Q34368122 | Riluzole Ameliorates Harmaline-induced Tremor in Rat. |
| Q39080963 | Riluzole activates TRPC5 channels independently of PLC activity |
| Q48726185 | Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. |
| Q48612819 | Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS. |
| Q44620461 | Riluzole reduces arrhythmias and myocardial damage induced by coronary occlusion in anaesthetized pigs |
| Q38773606 | The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions. |
| Q46097844 | The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. |
| Q35312769 | The dystrophin-associated protein complex maintains muscle excitability by regulating Ca(2+)-dependent K(+) (BK) channel localization |
| Q28288745 | The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models |
Search more.